104 related articles for article (PubMed ID: 2161934)
1. A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
Eriksson B; Risberg B
J Trauma; 1990 Jun; 30(6):753-4. PubMed ID: 2161934
[No Abstract] [Full Text] [Related]
2. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
[TBL] [Abstract][Full Text] [Related]
3. The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study.
Jørgensen PS; Knudsen JB; Broeng L; Josephsen L; Bjerregaard P; Hagen K; Jørgensen PK; Tørholm C
Clin Orthop Relat Res; 1992 May; (278):95-100. PubMed ID: 1314147
[TBL] [Abstract][Full Text] [Related]
4. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
[TBL] [Abstract][Full Text] [Related]
6. [The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. A placebo controlled trial].
Jørgensen PS; Knudsen JB; Broeng L; Josephsen IL; Bjerregaard P; Hagen KK; Jørgensen PK; Tørholm C
Ugeskr Laeger; 1993 Mar; 155(10):706-8. PubMed ID: 8384388
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
Moreno Gonzalez E; Fontcuberta J; de la Llama F
Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
[TBL] [Abstract][Full Text] [Related]
8. Can low-dose aspirin prevent thromboembolic phenomena in patients undergoing surgery for hip fracture or elective arthroplasty?
Henley E
J Fam Pract; 2000 Jul; 49(7):598-9. PubMed ID: 10923565
[No Abstract] [Full Text] [Related]
9. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
[TBL] [Abstract][Full Text] [Related]
10. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
11. [Low molecular weight heparins].
Agnelli G; Cosmi B
Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
[TBL] [Abstract][Full Text] [Related]
12. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery].
Grunebaum L; Fricker JP; Wiesel ML; Vergnes Y; Kapps J; Cazenave JP
J Mal Vasc; 1987; 12 Suppl B():102-4. PubMed ID: 2834478
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin ( a prospective, randomized study)].
Platz A; Hoffmann R; Kohler A; Bischof T; Trentz O
Z Unfallchir Versicherungsmed; 1993; 86(3):184-8. PubMed ID: 8130009
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
Couturaud F; Julian JA; Kearon C
Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
[TBL] [Abstract][Full Text] [Related]
17. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
Eriksson BI; Lassen MR;
Arch Intern Med; 2003 Jun; 163(11):1337-42. PubMed ID: 12796070
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
19. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
Diener HC
MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
[No Abstract] [Full Text] [Related]
20. [Low molecular heparin in prevention of thrombosis in orthopedic surgery].
Jensen HP; Borris LC; Lassen MR; Sørensen JV; Rahr HB; Christiansen HM; Ejstrud P
Ugeskr Laeger; 1993 Apr; 155(15):1109-15. PubMed ID: 8387708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
